Personensuche
X
?
1
Mean SARS-CoV-2 viral load log 10 between groups:
Bruno Martins Tomazini ; Lucas Tramujas ; Fernando Azevedo Medrado Junior...
https://figshare.com/articles/figure/Mean_SARS-CoV-2_viral_load_log_10_between_groups_/25277694. , 2024
https://figshare.com/articles/figure/Mean_SARS-CoV-2_viral_load_log_10_between_groups_/25277694. , 2024
?
2
Pfaffia paniculata Extract, a Potential Antimicrobial Agent..:
Miranda, Diego, Garcia ; De Paula Ramos, Lucas ; Attik, Nina...
info:eu-repo/semantics/altIdentifier/doi/10.3390/microorganisms12061165. , 2024
info:eu-repo/semantics/altIdentifier/doi/10.3390/microorganisms12061165. , 2024
?
3
Nausea-free days up to day 10:
Bruno Martins Tomazini ; Lucas Tramujas ; Fernando Azevedo Medrado Junior...
https://figshare.com/articles/figure/Nausea-free_days_up_to_day_10_/25277670. , 2024
https://figshare.com/articles/figure/Nausea-free_days_up_to_day_10_/25277670. , 2024
?
4
Nausea-free days up to day 10:
Bruno Martins Tomazini ; Lucas Tramujas ; Fernando Azevedo Medrado Junior...
doi:10.1371/journal.pone.0299197.s018. , 2024
doi:10.1371/journal.pone.0299197.s018. , 2024
?
5
Model of follow-up telephone interviews:
Bruno Martins Tomazini ; Lucas Tramujas ; Fernando Azevedo Medrado Junior...
doi:10.1371/journal.pone.0299197.s004. , 2024
doi:10.1371/journal.pone.0299197.s004. , 2024
?
6
Table_1_Assessment of risk scores to predict mortality of C..:
Matheus Carvalho Alves Nogueira ; Vandack Nobre ; Magda Carvalho Pires...
doi:10.3389/fmed.2023.1130218.s001. , 2024
doi:10.3389/fmed.2023.1130218.s001. , 2024
?
7
Table_2_Assessment of risk scores to predict mortality of C..:
Matheus Carvalho Alves Nogueira ; Vandack Nobre ; Magda Carvalho Pires...
doi:10.3389/fmed.2023.1130218.s002. , 2024
doi:10.3389/fmed.2023.1130218.s002. , 2024
?
8
Study outcomes:
Bruno Martins Tomazini ; Lucas Tramujas ; Fernando Azevedo Medrado Junior...
https://figshare.com/articles/dataset/Study_outcomes_/25277700. , 2024
https://figshare.com/articles/dataset/Study_outcomes_/25277700. , 2024
?
9
Symptoms free-days up to day 10:
Bruno Martins Tomazini ; Lucas Tramujas ; Fernando Azevedo Medrado Junior...
doi:10.1371/journal.pone.0299197.g002. , 2024
doi:10.1371/journal.pone.0299197.g002. , 2024
?
10
Symptoms-free days up to day 10:
Bruno Martins Tomazini ; Lucas Tramujas ; Fernando Azevedo Medrado Junior...
doi:10.1371/journal.pone.0299197.s010. , 2024
doi:10.1371/journal.pone.0299197.s010. , 2024
?
11
Flow of patients in Halos trial:
Bruno Martins Tomazini ; Lucas Tramujas ; Fernando Azevedo Medrado Junior...
https://figshare.com/articles/figure/Flow_of_patients_in_Halos_trial_/25277685. , 2024
https://figshare.com/articles/figure/Flow_of_patients_in_Halos_trial_/25277685. , 2024
?
12
Dyspnea-free days up to day 10:
Bruno Martins Tomazini ; Lucas Tramujas ; Fernando Azevedo Medrado Junior...
doi:10.1371/journal.pone.0299197.s015. , 2024
doi:10.1371/journal.pone.0299197.s015. , 2024
?
13
Other symptoms-free days up to day 10:
Bruno Martins Tomazini ; Lucas Tramujas ; Fernando Azevedo Medrado Junior...
doi:10.1371/journal.pone.0299197.s021. , 2024
doi:10.1371/journal.pone.0299197.s021. , 2024
?
14
Study outcomes:
Bruno Martins Tomazini ; Lucas Tramujas ; Fernando Azevedo Medrado Junior...
doi:10.1371/journal.pone.0299197.t002. , 2024
doi:10.1371/journal.pone.0299197.t002. , 2024
?
15
Adverse Events at day 28:
Bruno Martins Tomazini ; Lucas Tramujas ; Fernando Azevedo Medrado Junior...
doi:10.1371/journal.pone.0299197.s008. , 2024
doi:10.1371/journal.pone.0299197.s008. , 2024
1-15
